Status and phase
Conditions
Treatments
About
Comparison of treatment cost of knee osteoarthritis (OA) in patients treated with Synvisc® versus usual treatments as well as evaluation of safety and effectiveness of these treatments.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Patient suffering from acute congestive osteoarthritis flare of the target knee (at the time of inclusion) which means that concomitantly to knee effusion at least 2 of the following criteria are present:
Intra-articular administration of hyaluronic acid in the target knee within the previous year
Intra-articular administration of hyaluronic acid in the target knee within the three previous months
Any other intra-articular injection in the target knee within the last 6 months
Any contraindication to intra-articular injections
Present or past history of infected target knee joint
Previous prosthesis knee surgery, tibial osteotomy, synovectomy or synoviorthese of the target knee
Arthroscopy, articular lavage, debridement, menisectomy of the target knee within the previous year
Planned knee surgery within the nine following month
Any other musculoskeletal disorders that can interfere with osteoarthritis diagnosis or the evaluation of its severity
Known hypersensitivity to avian products
Presence of lymphatic or venous stasis
Pregnancy or breastfeeding
Clinical evidence of or known severe cardiac, hepatic, renal, metabolic, haematological disease, mental disturbance
Participation in another clinical trial during this study or during the previous month
Previous participation in this trial
Patient who requires help concerning shopping or house keeping
Patient unable to comply with the protocol (e.g. patient unable to attend each trial visit or to fill the diary booklet or the quality of life questionnaire)
Primary purpose
Allocation
Interventional model
Masking
518 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal